Entry |
|
Name |
Eliapixant (USAN/INN) |
Formula |
C22H21F3N4O3S
|
Exact mass |
478.1286
|
Mol weight |
478.49
|
Structure |

|
Class |
Unclassified
DG03292 Purinergic receptor P2X 3 antagonist
|
Efficacy |
Analgesic, P2X3 receptor antagonist |
Comment |
Treatment of chronic cough, pain associated with endometriosis, overactive bladder and pain associated with diabetic peripheral neuropathy
|
Target |
|
Pathway |
hsa04080 | Neuroactive ligand-receptor interaction |
|
Brite |
Drug groups [BR:br08330]
Unclassified
DG03292 Purinergic receptor P2X 3 antagonist
D12323 Eliapixant
Target-based classification of drugs [BR:br08310]
Ion channels
Ligand-gated ion channels
ATP-gated cation channel (P2X)
P2RX3
D12323 Eliapixant (USAN/INN)
|
Other DBs |
|
LinkDB |
|
KCF data |
ATOM 33
1 C8y C 18.9000 -18.5500
2 C8x C 18.9000 -17.1500
3 C8y C 20.0900 -16.4500
4 C8x C 21.3500 -17.1500
5 C8y C 21.3500 -18.5500
6 C8x C 20.0900 -19.2500
7 O2a O 17.7100 -19.2500
8 C1y C 16.5200 -18.5500
9 C1x C 15.2600 -19.1100
10 O2x O 14.3500 -18.1300
11 C1x C 14.9800 -16.9400
12 C1x C 16.3800 -17.2200
13 C5a C 22.5400 -19.2500
14 N1b N 23.7300 -18.5500
15 O5a O 22.5400 -20.6500
16 C1c C 24.9200 -19.2500
17 C8y C 26.1100 -18.5500
18 C1a C 24.9200 -20.6500
19 C8x C 26.1100 -17.1500
20 N5x N 27.3700 -16.4500
21 C8y C 28.5600 -17.1500
22 N5x N 28.5600 -18.5500
23 C8x C 27.3700 -19.2500
24 C1d C 29.7500 -16.4500
25 X F 31.0100 -15.7500
26 X F 30.4500 -17.6400
27 X F 29.0500 -15.2600
28 C8y C 20.0900 -15.0500
29 S2x S 18.9700 -14.2100
30 C8y C 19.3900 -12.8800
31 C8x C 20.7900 -12.8800
32 N5x N 21.2800 -14.2100
33 C1a C 18.5500 -11.7600
BOND 36
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 1 7 1
8 8 7 1 #Up
9 8 9 1
10 9 10 1
11 10 11 1
12 11 12 1
13 8 12 1
14 5 13 1
15 13 14 1
16 13 15 2
17 14 16 1
18 16 17 1
19 16 18 1 #Up
20 17 19 2
21 19 20 1
22 20 21 2
23 21 22 1
24 22 23 2
25 17 23 1
26 21 24 1
27 24 25 1
28 24 26 1
29 24 27 1
30 3 28 1
31 28 29 1
32 29 30 1
33 30 31 2
34 31 32 1
35 28 32 2
36 30 33 1
|